维普中文期刊产品整合服务
10篇 您的检索式:作者名="Lingeng lu"
    题名 作者 年代 出处 被引量
1Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries显示文摘Background:Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(ICC)are the most common subtypes of primary liver cancer,but nationwide incidence of both liver cancer subtypes have never been reported in China.We aimed to estimate the most recent incidence of HCC and ICC and temporal trends in China based on the most updated data from high qualified population-based cancer registries(covering 13.1%of the national population),in comparison to those in the United States at the same period.Methods:We used data from 188 Chinese population-based cancer registries covering 180.6 million population of China to estimate the nationwide incidence of HCC and ICC in 2015.And 22 population-based cancer registries’data were used to estimate the trends of HCC and ICC incidence from 2006 to 2015.Multiple imputation by chained equations method was used to impute liver cancer cases with unknown subtype(50.8%).We used data from 18 population-based registries from the Surveillance,Epidemiology,and End Results program to analyze incidence of HCC and ICC in the United States.Results:In China,an estimated 301,500 and 61,900 newly diagnosed HCC and ICC occurred in 2015.The overall age-standardized rates(ASRs)of HCC incidence decreased by 3.9%per year.For ICC incidence,the overall ASR was relatively stable,but increased in the population of over 65 years old.Subgroup analysis by age showed that the ASR of HCC incidence had the sharpest decline in population who were less than 14 years old and received neonatally hepatitis B virus(HBV)vaccination.In the United States,though the incidence of HCC and ICC were lower than those in China,the overall HCC and ICC incidence increased by 3.3%and 9.2%per year.Conclusions:China still faces with a heavy burden of liver cancer incidence.Our results may further support the beneficial effect of Hepatitis B vaccination on reduction of HCC incidence.Both healthy lifestyle promotion and infection control are needed for future liver cancer control and prevention for China and the United States.Lan An Rongshou Zheng Siwei Zhang Ru Chen Shaoming Wang Kexin Sun Lingeng Lu Xuehong Zhang Hong Zhao Hongmei Zeng Wenqiang Wei Jie He 2023Hepatobiliary Surgery and Nutrition2023,12,1:4
2The relationship of insulin- like growth factor-2, insulin like growth factor binding protein-3, and estrogen receptor-π expression to disease progression in epithelial ovarian cancer显示文摘Lingeng lu Dionyssios Katsaros 2006Clin Cancer Res2006,12,4:1
3Pluripotent factor lin - 28 and its homologue lin -28b in epithelial ovarian cancer and their associa- tions with disease outcomes and expression of let - 7a and IGF - II显示文摘Lingeng Lu Dionyssios Katsaros 2009Euro J Cancer2009,45,12:1
4IGF-I in epithelial ovarian cancer and its role in disease progression显示文摘Jane Brokaw Dionyssios Katsaros Andrew Wiley Lingeng Lu Dan Su Olga Sochirca Irene A. Rigault de la Longrais Susan Mayne Harvey Risch Herbert Yu 2007Growth Factors2007,,5:1
5Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer显示文摘Lingeng Lu Guangjian Zhu Chong Zhang Qian Deng Dionyssios Katsaros Susan T. Mayne Harvey A. Risch Lina Mu Emilie Marion Canuto Gianluca Gregori Chiara Benedetto Herbert Yu 2012Breast Cancer Research and Treatment2012,,3:1
6MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management显示文摘Lingeng Lu Peter Schwartz Luca Scarampi Thomas Rutherford Emilie Marion Canuto Herbert Yu Dionyssios Katsaros 2011Gynecologic Oncology2011,,2:1
7Hypermethyla- tion of let-Ta-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favor-able prognosis显示文摘Lingeng Lu Dionyssios Katsaros Irene A 2007Cancer Res2007,67,10:1
8Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics显示文摘Lina Mu Dionyssios Katsaros Andrew Wiley Lingeng Lu Irene A. Rigault Longrais Stephanie Smith Sapna Khubchandani Olga Sochirca Riccardo Arisio Herbert Yu 2009Breast Cancer Research and Treatment2009,,1:1
9High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1显示文摘Biyun Qian Dionyssios Katsaros Lingeng Lu Mario Preti Antonio Durando Riccardo Arisio Lina Mu Herbert Yu 2009Breast Cancer Research and Treatment2009,,1:1
10Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II显示文摘Lingeng Lu Dionyssios Katsaros Khvaramze Shaverdashvili Biyun Qian Yixing Wu Irene A. Rigault de la Longrais Mario Preti Guido Menato Herbert Yu 2009European Journal of Cancer2009,,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费